Home
PB Ratio of Divis Laboratories Ltd

Divis Laboratories Ltd
NSE: DIVISLAB
PB Ratio
Key Highlights
- The latest PB Ratio of Divis Laboratories Ltd is 10.6.
- The PB ratio of the Divis Laboratories Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
- The P/B Ratio of Divis Laboratories Ltd changed from 7.2 on March 2020 to 6.7 on March 2024 . This represents a CAGR of -1.43% over 5 years.
Historical P/B Ratio of Divis Laboratories Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Divis Laboratories Ltd
Company Fundamentals for Divis Laboratories Ltd
Market Cap
145,762 Cr
EPS
77.9
P/E Ratio (TTM)
70.5
P/B Ratio (TTM)
10.6
Day’s High
5799.1
Day’s Low
5383.45
DTE
0.0
ROE
13.4
52 Week High
6448.75
52 Week Low
3640.1
ROCE
18.4
Market Price of Divis Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
04 Apr 2025 | 5490.75 |
03 Apr 2025 | 5761.35 |
02 Apr 2025 | 5663.3 |
01 Apr 2025 | 5548.5 |
28 Mar 2025 | 5773.1 |
27 Mar 2025 | 5855.2 |
26 Mar 2025 | 5839.45 |
25 Mar 2025 | 5837.4 |
24 Mar 2025 | 5909.5 |
21 Mar 2025 | 5795.55 |
SWOT Analysis Of Divis Laboratories Ltd
BlinkX Score for Divis Laboratories Ltd
Asset Value vs Market Value of Divis Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
Company | PB | Market Cap |
---|
Divis Laboratories Ltd | 10.63 | 145762 |
Sun Pharmaceutical Industries Ltd | 98.3 | 410142 |
Cipla Ltd | 360.7 | 114322 |
Torrent Pharmaceuticals Ltd | 222.4 | 111166 |
Mankind Pharma Ltd | 334.2 | 101098 |
Company | |
---|---|
Divis Laboratories Ltd | 10.63 |
Sun Pharmaceutical Industries Ltd | 98.3 |
Cipla Ltd | 360.7 |
Torrent Pharmaceuticals Ltd | 222.4 |
Mankind Pharma Ltd | 334.2 |
PB Ratio of Divis Laboratories Ltd Explained
₹145762
Market cap
₹517
Book Value per Share
10.6X
PB Ratio
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.
How to calculate Price-to-Book (P/B) Ratio?
The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.
Market capitalization = market value of a stock X no. of outstanding shares
Now, you need to know the net value of an organization's assets.
Book Value of Assets = Total Assets - Total Liabilities of a company
After knowing the value of the above ratios, here is the formula for the P/B Ratio:
P/B Ratio = Market Capitalization/ Book Value of Assets
or you can also use this formula
P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical Market Cap of Divis Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Divis Laboratories Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Divis Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Divis Laboratories Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Divis Laboratories Ltd News Hub
Divis Laboratories Ltd rises for third straight session
Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs 4884.75,
Read more
21 Aug 24
Divis Lab Q1 PAT climbs 21% YoY to Rs 430 cr
Revenue from operations grew by 19.12% year on year to Rs 2,118 crore in the quarter ended 30 June 2
Read more
03 Aug 24
Divi's Laboratories consolidated net profit rises 20.79% in the June 2024 quarter
Net profit of Divi's Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as a
Read more
03 Aug 24
Divis Laboratories Ltd up for third straight session
Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5151.7,
Read more
05 Sept 24
Document
Concalls
May 2024
TranscriptFeb 2024
TranscriptAug 2023
TranscriptMay 2023
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptJan 2021
TranscriptMay 2024
TranscriptFeb 2024
TranscriptAug 2023
TranscriptMay 2023
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptJan 2021
Transcript